Politecnico di Milano, Dipartimento di Chimica, Materiali e Ingegneria Chimica G. Natta, Milano, Italy.
Thromb Haemost. 2010 Mar;103(3):613-22. doi: 10.1160/TH09-02-0084. Epub 2010 Feb 2.
Hydrogen peroxide (H2O2) and Cu(OAc)2 or FeSO4 (Fenton type reagents) perform heparin (Hep) depolymerisation to low-molecular-weight heparin (LMWH) following a radical chain mechanism. Hydroxyl (OH) radicals which are initially generated from H2O2 reduction by transition metal ions abstract hydrogen atoms on the heparin chain providing carbon centred radicals whose decay leads to the depolymerisation process. The main depolymerisation mechanism involves Hep radical intermediates that cleave the glycosidic linkage at unsulphated uronic acids followed by a 6-O-nonsulphated glucosamine, thus largely preserving the pentasaccharide sequence responsible for the binding to antithrombin III (AT). Both the transition metal ions influence the overall efficiency of the radical chain processes: Fe2+ acting as a catalyst, while Cu2+ acts as a reagent. LMWHs, especially those afforded by Cu2+, are somewhat unstable to the usual basic workup. However, this lack of stability can be eliminated by a previous NaBH4 reduction. Furthermore, with Cu2+, the process is much more reproducible than with Fe2+. Therefore, for the process of Fenton type depolymerisation of heparin, the use of Cu(OAc)2 is clearly preferable to the more "classical" FeSO4. The resulting activities and characteristics of these LMWHs are peculiar to these oxidative radical processes. In addition, LMWH provided by H2O2/Cu(OAc)2 in optimised conditions was found to posses anti-Xa and anti-IIa activities comparable to those of LMWHs currently in clinical use.
过氧化氢(H2O2)和 Cu(OAc)2 或 FeSO4(芬顿型试剂)通过自由基链式机制将肝素(Hep)解聚为低分子量肝素(LMWH)。羟基(OH)自由基最初是由过渡金属离子还原 H2O2 产生的,它从肝素链上夺取氢原子,提供碳中心自由基,其衰减导致解聚过程。主要的解聚机制涉及 Hep 自由基中间体,它们在未硫酸化的糖醛酸处切开糖苷键,然后是 6-O-非硫酸化的葡萄糖胺,从而在很大程度上保留了与抗凝血酶 III(AT)结合的五糖序列。两种过渡金属离子都影响自由基链式过程的整体效率:Fe2+ 作为催化剂,而 Cu2+ 作为试剂。LMWHs,特别是由 Cu2+ 提供的那些,对通常的碱性工作条件有些不稳定。然而,这种不稳定性可以通过先前的 NaBH4 还原消除。此外,Cu2+ 的使用使过程比 Fe2+ 更具重现性。因此,对于肝素的芬顿型解聚过程,使用 Cu(OAc)2 显然优于更“经典”的 FeSO4。这些 LMWHs 的产生的活性和特性是这些氧化自由基过程所特有的。此外,在优化条件下由 H2O2/Cu(OAc)2 提供的 LMWH 被发现具有抗 Xa 和抗 IIa 活性,可与目前临床使用的 LMWH 相媲美。